Wadhera Rishi K, Joynt Maddox Karen E, Fonarow Gregg C, Zhao Xin, Heidenreich Paul A, DeVore Adam D, Matsouaka Roland A, Hernandez Adrian F, Yancy Clyde W, Bhatt Deepak L
Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (R.K.W., D.L.B.).
Division of Cardiology, Richard and Susan Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical and Harvard Medical School, Boston, MA (R.K.W.).
Circ Cardiovasc Qual Outcomes. 2018 Jul;11(7):e004729. doi: 10.1161/CIRCOUTCOMES.118.004729.
Heart failure (HF) is the leading cause of morbidity and mortality in the United States. Despite advancement in the management of HF, outcomes remain suboptimal, particularly among the uninsured. In 2014, the Affordable Care Act expanded Medicaid eligibility, and millions of low-income adults gained insurance. Little is known about Medicaid expansion's effect on inpatient HF care.
We used the American Heart Association's Get With The Guidelines-Heart Failure registry to assess changes in inpatient care quality and outcomes among low-income patients (<65 years old) hospitalized for HF after Medicaid expansion, in expansion, and nonexpansion states. Patients were classified as low-income if covered by Medicaid, uninsured, or missing insurance. Expansion states were those that implemented expansion in 2014. Piecewise logistic multivariable regression models were constructed to track quarterly trends of quality and outcome measures in the pre (January 1, 2010-December 31, 2013) and postexpansion (January 1, 2014-June 30, 2017) periods. These measures were compared between expansion versus nonexpansion states during the postexpansion period. The cohort included 58 804 patients hospitalized across 391 sites. In states that expanded Medicaid, uninsured HF hospitalizations declined from 7.9% to 4.4%, and Medicaid HF hospitalizations increased from 18.3% to 34.6%. Defect-free HF care was increasing during the preexpansion period (adjusted odds ratio/quarter, 1.06; 95% confidence interval, 1.03-1.08) but did not change after expansion (adjusted odds ratio, 0.99; 95% confidence interval, 0.97-1.02). Patterns were similar for other quality measures. There were no quality measures for which the rate of improvement sped up after expansion. In-hospital mortality rates remained similar during the preexpansion (adjusted odds ratio, 0.99; 95% confidence interval, 0.96-1.02) and postexpansion periods (adjusted odds ratio, 1.00; 95% confidence interval, 0.97-1.03). Among nonexpansion states, uninsured HF hospitalizations increased (11.6% to 16.7%) as did Medicaid HF hospitalizations (17.9% to 26.6%), and no quarterly improvement was observed for most quality measures in the post compared with preexpansion period. During the postexpansion period, defect-free care and mortality did not differ between expansion and nonexpansion states.
Medicaid expansion was associated with a significant decline in uninsured HF hospitalizations but not improvements in quality of care or in-hospital mortality among sites participating in a national quality improvement initiative. Efforts beyond insurance expansion are needed to improve in-hospital outcomes for low-income patients with HF.
心力衰竭(HF)是美国发病和死亡的主要原因。尽管心力衰竭的管理取得了进展,但其治疗效果仍不尽人意,尤其是在未参保人群中。2014年,《平价医疗法案》扩大了医疗补助资格,数百万低收入成年人获得了保险。关于医疗补助扩大对住院心力衰竭治疗的影响,人们知之甚少。
我们使用美国心脏协会的“遵循指南-心力衰竭”注册系统,评估医疗补助扩大后、扩大期间以及未扩大州中因心力衰竭住院的低收入患者(<65岁)的住院治疗质量和结果的变化。如果患者参加医疗补助、未参保或保险信息缺失,则被归类为低收入患者。扩大州是指在2014年实施扩大的州。构建分段逻辑多变量回归模型,以跟踪扩张前(2010年1月1日至2013年12月31日)和扩张后(2014年1月1日至2017年6月30日)期间质量和结果指标的季度趋势。在扩张后期间,对扩张州和未扩张州的这些指标进行了比较。该队列包括在391个地点住院的58804名患者。在扩大医疗补助的州,未参保的心力衰竭住院患者比例从7.9%降至4.4%,而参加医疗补助的心力衰竭住院患者比例从18.3%增至34.6%。在扩张前期间,无缺陷的心力衰竭护理呈上升趋势(调整后的比值比/季度为1.06;95%置信区间为1.03 - 1.08),但扩张后没有变化(调整后的比值比为0.99;95%置信区间为0.97 - 1.02)。其他质量指标的模式相似。没有质量指标在扩张后改善速度加快。住院死亡率在扩张前(调整后的比值比为0.99;95%置信区间为0.96 - 1.02)和扩张后期间(调整后的比值比为1.00;95%置信区间为0.97 - 1.03)保持相似。在未扩大州,未参保的心力衰竭住院患者增加(从11.6%增至16.7%),参加医疗补助的心力衰竭住院患者也增加(从17.9%增至26.6%),与扩张前相比,扩张后大多数质量指标没有季度改善。在扩张后期间,扩张州和未扩张州在无缺陷护理和死亡率方面没有差异。
医疗补助扩大与未参保的心力衰竭住院患者显著减少相关,但对于参与全国质量改进计划的机构,护理质量和住院死亡率并未改善。需要采取保险扩张以外的措施来改善低收入心力衰竭患者的住院结局。